Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies

Qamar Abuhassan ¹ , Kamel Saleh ² * , S. Renuka Jyothi ³, Radhamadhab Sahoo ⁴, P. Prakash ⁵, Gunjan Mukherjee ⁶, Aashna Sinha ⁷, Turabek Boyqulov ⁸

Cited by CrossRef: 0

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons